Quarterly report pursuant to Section 13 or 15(d)

Share-Based Compensation (Details)

v3.21.2
Share-Based Compensation (Details)
3 Months Ended 9 Months Ended
Sep. 30, 2021
USD ($)
shares
Sep. 30, 2021
USD ($)
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Share-based compensation expense | $ $ 1,500,000 $ 4,600,000
Unrecognized compensation expense | $ $ 200,500,000 $ 200,500,000
Performance-based Restricted Stock    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of awards outstanding (in shares) 30,200,000 30,200,000
Share-based compensation expense | $   $ 0
Restricted Stock    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Antidilutive securities excluded from computation of loss per share amount (in shares)   30,200,000
Stock Options    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Antidilutive securities excluded from computation of loss per share amount (in shares)   11,100,000
FID | Tranche one | Performance-based Restricted Stock    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of awards outstanding (in shares) 10,200,000 10,200,000
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage   33.33%
FID | Tranche Two | Performance-based Restricted Stock    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of awards outstanding (in shares) 19,200,000 19,200,000
Other criteria | Performance-based Restricted Stock    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of awards outstanding (in shares) 800,000 800,000
2016 Plan    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of common stock authorized for issuance (in shares) 40,000,000 40,000,000